Evidence map›Paper›PMID 20885955›Full record

ArticlePloS one2010

Epigenetic modifiers are necessary but not sufficient for reprogramming non-myelinating cells into myelin gene-expressing cells.

Jia Liu, Juan Sandoval, Sung Tae Doh, Li Cai, Gerardo López-Rodas, Patrizia Casaccia

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. EPIGENETIC MECHANISMS IN MULTIPLE SCLEROSIS.Revista espanola de esclerosis multiple · 2014
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. DNA methylation in stem cell renewal and multipotency.Stem cell research & therapy · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Jia LiuDepartment of Neuroscience, Mount Sinai School of Medicine, New York, New York, United States of America.
Juan Sandoval
Sung Tae Doh
Li Cai
Gerardo López-Rodas
Patrizia Casaccia
Icahn School of Medicine at Mount Sinai · USRutgers, The State University of New Jersey · USUniversitat de València · ES

Funding

Histone deacetylation in oligodendrocyte differentiationR01NS042925 · NINDS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI CASACCIA, PATRIZIA · 2003 to 2011
$3.9M
Comparative genomic and molecular genetics approaches to retinal stem cellsR21EY018738 · NEI · RUTGERS, THE STATE UNIV OF N.J. · PI CAI, LI · 2008 to 2009
$412k
NEI NIH HHS R21 EY018738NEI NIH HHS R21-EY018738NINDS NIH HHS NS-R01-42925-08NINDS NIH HHS NS-R01-42925-08-S1NINDS NIH HHS R01 NS042925
6 · The paper itself

Abstract

backgroundModifications on specific histone residues and DNA methylation play an essential role in lineage choice and cellular reprogramming. We have previously shown that histone modifications or combinatorial codes of transcription factors (TFs) are critical for the differentiation of multipotential progenitors into myelinating oligodendrocytes. In this study we asked whether combining global manipulation of DNA methylation and histone acetylation together with the expression of oligodendrocyte-specific TFs, was sufficient to switch the identity of fibroblasts into myelin gene-expressing cells. METHODOLOGY/PRINCIPAL

findingsTransfection of six oligodendrocyte-specific TFs (Olig1, Olig2, Sox10, Mash1, E47 and Nkx2.2) into NIH3T3 fibroblasts was capable of inducing expression of myelin gene promoter-driven reporters, but did not activate endogenous myelin gene expression. These results suggested the existence of a transcriptionally incompetent chromatin conformation in NIH3T3 fibroblasts. Using chromatin immunoprecipitation (ChIP) analysis, we compared the histone code on the conserved regions of myelin genes (i.e. Mbp and Mag) in differentiating oligodendrocyte progenitors and NIH3T3 fibroblasts. Chromatin at myelin gene loci was characterized by the presence of repressive histone modifications (me3K9H3 and me3K27H3) in NIH3T3 fibroblasts and active histone marks (me3K4H3 and AcH3) in oligodendrocyte lineage cells. To induce a transcriptionally competent chromatin signature, NIH3T3 fibroblasts were treated with 5-azadeoxy-citidine (5-AzaC) to decrease DNA methylation, and trichostatin A (TSA) or sirtinol, to favor histone acetylation. Treatment with 5-AzaC/TSA but not sirtinol, resulted in the detection of endogenous myelin gene transcripts in fibroblasts, although not to the levels detected in myelinating cells. Transfection of oligodendrocyte-specific TFs after 5-AzaC/TSA treatment did not further increase myelin gene expression, nor did it reprogram the transcriptional network of NIH3T3 fibroblasts into that of oligodendrocytes. CONCLUSIONS/SIGNIFICANCE: These results suggest that reprogramming of fibroblasts into myelin gene-expressing cells not only requires transcriptional activation, but also chromatin manipulations that go beyond histone acetylation and DNA methylation.

Indexed as

Cell DifferentiationEpigenesis, GeneticGene ExpressionAcetylationAnimalsCell LineCell LineageCells, CulturedChromatinDNA MethylationFibroblastsHistonesHomeobox Protein Nkx-2.2MiceMultipotent Stem CellsMyelin ProteinsChromatinHistonesHomeobox Protein Nkx-2.2Myelin ProteinsNkx2-2 protein, mouseNkx2-2 protein, ratTranscription Factors

Identifiers

PMID20885955
PMCPMC2946387
OpenAlexW2024390549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.